Trials / Completed
CompletedNCT00117052
SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary Hyperparathyroidism
SENSOR: Study to InvestigatE Cinacalcet TreatmeNt in Haemodialysis Patients With SecOndary HyperparathyRoidism
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 673 (actual)
- Sponsor
- Amgen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate that the efficacy of cinacalcet when co-administered with the first meal after dialysis is comparable (non-inferior) to the efficacy of cinacalcet when administered during the dialysis study visit.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | cinacalcet | All eligible subjects were assigned to receive once daily oral doses of cinacalcet, but were randomised in a 1:1 ratio to receive the drug either with the first meal after dialysis or during the dialysis visit on dialysis days. |
Timeline
- Start date
- 2004-09-01
- Primary completion
- 2005-11-01
- Completion
- 2006-02-01
- First posted
- 2005-07-04
- Last updated
- 2013-05-23
Source: ClinicalTrials.gov record NCT00117052. Inclusion in this directory is not an endorsement.